This case is notable for two key features: (1) insulinoma presenting primarily with postprandial hypoglycemia and (2) symptom exacerbation following initiation of tirzepatide, a dual GIP/GLP-1 RA. The gene discussed is GIP; the disease is Hypoglycemia.